about
The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, RussiaTuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda.Two vicious circles contributing to a diagnostic delay for tuberculosis patients in Arkhangelsk.Hopelessness as a basis for tuberculosis diagnostic delay in the Arkhangelsk region: a grounded theory study.Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010.Incidence of tuberculosis and associations with indicators of alcohol consumption in three regions of northwest Russia in 1975-2009: a time-series analysis.A comparison between passive and active case finding in TB control in the Arkhangelsk region.Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting.Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.Outbreak of tuberculosis in a closed setting: views on transmission based on results from molecular and conventional methods.Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.Drug-resistant tuberculosis threatens WHO's End-TB strategy.Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype.WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateTreatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysisTuberculosis in the Circumpolar Region, 2006-2012Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgeryCost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian FederationTreatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant TuberculosisImpact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosisDiagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia
P50
Q28551241-77DC45D5-DF38-480D-BD3E-C00941890021Q33719927-E30F08AC-2B26-4A6F-942D-FA5609387319Q34099907-F389909C-1050-4E21-A55B-5CC43C8DE2A3Q34895033-122B9FC3-90E4-4E11-8D09-2AB169219F54Q35673493-120C8915-4093-4A31-8EA2-CBCE2AAD00CCQ36956124-A22ACE0A-FD80-4B02-956A-7E35C9D2DF8EQ37590749-81E37EB8-B022-4D35-87E4-B78A9DBB96A5Q38915347-B6DE553D-E78B-4C23-B053-3947A6E8D7C7Q39122423-A677253E-7E75-4C3A-96CD-DD5E64A8BD78Q40088037-01D05FDC-D098-48A4-8D16-263B2A56E010Q40113350-04A860DB-3B6C-4ABF-9433-43BFEB1B6D1CQ40702860-98A97161-39C0-441D-900A-CA72A58239FDQ44564499-B567A9A5-8740-417E-9A9C-60C4A929480FQ45293026-576BF17D-B825-400B-BF55-C227B52132B1Q50643380-62C738B0-5D9D-46B7-8D69-85F7DD156B51Q53883061-45EC7E95-EBD8-43E7-9096-FCC85E91E109Q56838263-3B4C783A-1504-4594-835D-36DC606846F2Q56889741-363581C3-C047-4DD2-AFAF-9BF2D2877FA8Q57102140-80E66BDF-F050-44FB-8808-9C43A3A60782Q57677554-63D68A37-AEE7-4F43-93D3-ABBE8BAEA4BBQ61807571-5433D627-9EA5-4825-9D88-CC6E50162F42Q64076113-6A5860E0-6EAB-45F4-99E8-49E9D0C26D6AQ75306259-8114DA8C-6185-4519-8422-BD0DAEAA2E54Q92089254-5B80FFA6-5C61-4838-BB89-221955A7BD12Q92517257-8301257A-DAF7-422D-80E3-5C049E3E4F39
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrey Maryandyshev
@ast
Andrey Maryandyshev
@en
Andrey Maryandyshev
@es
Andrey Maryandyshev
@nl
type
label
Andrey Maryandyshev
@ast
Andrey Maryandyshev
@en
Andrey Maryandyshev
@es
Andrey Maryandyshev
@nl
prefLabel
Andrey Maryandyshev
@ast
Andrey Maryandyshev
@en
Andrey Maryandyshev
@es
Andrey Maryandyshev
@nl
P106
P31
P496
0000-0002-8485-5625